Varenicline’s molecular mechanisms in neuropsychiatric disorders reviewed
A new review examines how the α4β2 nicotinic receptor agonist varenicline might act on molecular pathways involved in neuropsychiatric disorders.
A new review examines how the α4β2 nicotinic receptor agonist varenicline might act on molecular pathways involved in neuropsychiatric disorders.
A Danish birth cohort study found that offspring with high prenatal acrylamide exposure, measured in maternal blood, had significantly higher ...
A Bayesian multi-omics analysis of GWAS and blood and brain QTL data has identified 86 gene-protein associations across nine neuropsychiatric ...
A new mouse study shows that electroconvulsive treatment can drive hippocampal neurons back to an immature state only from about ...
A new review in Translational Psychiatry identifies the TCF/LEF transcription factor family as central nuclear effectors of Wnt/β-catenin signaling and ...
A new review argues that visual snow syndrome is a multisystem neuropsychiatric network disorder in which visual cortical hyperexcitability, thalamocortical ...
Despite extraordinary advances in biomedical science, neuropsychiatric disorders continue to impose one of the largest health burdens on societies worldwide. ...
In a compelling new discovery that could reshape our understanding of psychosis and its early markers, researchers have identified a ...
In a groundbreaking study, researchers have delved into the intricate workings of the brain’s procedural memory network, unveiling significant alterations ...
In a groundbreaking study led by researchers Mohammadkhanloo, Sharini, and Yousefpour, significant insights have emerged regarding the intricate relationship between ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine